BMC Anesthesiology (Jun 2023)

Heparin-resistance in AL amyloidosis: a case report

  • Elisabeth S. van Ede,
  • Marlijn P. A. Hoeks,
  • Jan Hofland,
  • Vera D. Linssen,
  • Toin H. van Kuppevelt,
  • Elly M. Versteeg,
  • Theo G. Hafmans,
  • Arjan Diepstra,
  • Benno Kusters,
  • Sanne M. M. Vermorgen

DOI
https://doi.org/10.1186/s12871-023-02147-4
Journal volume & issue
Vol. 23, no. 1
pp. 1 – 7

Abstract

Read online

Abstract Background Non-AT-III mediated heparin-resistance during CPB occurs by complex-forming with heparin-binding proteins. Currently, there are no specific recommendations for non-AT-III mediated heparin-resistance. Case presentation We present a fatal case of a 70-yr-old male-patient undergoing cardiac-surgery in which refractory heparin-resistance was observed. The massive AL amyloidosis found at autopsy is thought to be responsible and illustrates that awareness and knowledge of the etiology and perioperative strategies of non-AT-III mediated heparin-resistance is important. Conclusion For anticoagulation during cardiopulmonary bypass surgery in case of a non-AT-III medicated heparin resistance, we refer to the decision tree added to this manuscript and if necessary to consider direct thrombin inhibitors, such as bivalirudin or argatroban, as it bypasses the complexing pathway.

Keywords